-
公开(公告)号:US07659268B2
公开(公告)日:2010-02-09
申请号:US11804726
申请日:2007-05-18
Applicant: Sara Hadida-Ruah , Matthew Hamilton , Mark Miller , Peter D. J. Grootenhuis , Brian Bear , Jason McCartney , Jinglan Zhou , Frederick van Goor
Inventor: Sara Hadida-Ruah , Matthew Hamilton , Mark Miller , Peter D. J. Grootenhuis , Brian Bear , Jason McCartney , Jinglan Zhou , Frederick van Goor
IPC: A61K31/5377 , A61K31/497 , A61K31/506 , A61K31/4418 , A61K31/443 , C07D413/00 , C07D401/00 , C07D213/02 , C07D405/00
CPC classification number: C07D405/12 , A61K31/443 , A61K31/444 , A61K31/4545 , A61K31/47 , A61K31/4709 , A61K31/496 , A61K31/497 , A61K31/501 , A61K31/506 , A61K31/5377 , A61K45/06 , C07D405/14
Abstract: Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.
Abstract translation: 本发明的化合物及其药学上可接受的组合物可用作ATP结合盒(“ABC”)转运蛋白或其片段的调节剂,包括囊性纤维化跨膜电导调节剂(“CFTR”)。 本发明还涉及使用本发明化合物治疗ABC转运蛋白介导的疾病的方法。
-
公开(公告)号:US07645789B2
公开(公告)日:2010-01-12
申请号:US11975297
申请日:2007-10-18
Applicant: Sara S. Hadida Ruah , Peter D. J. Grootenhuis , Fredrick Van Goor , Jinglan Zhou , Brian Bear , Mark T. Miller , Jason McCartney , Mehdi Michel Djamel Numa
Inventor: Sara S. Hadida Ruah , Peter D. J. Grootenhuis , Fredrick Van Goor , Jinglan Zhou , Brian Bear , Mark T. Miller , Jason McCartney , Mehdi Michel Djamel Numa
IPC: A61K31/36 , C07D405/12
CPC classification number: A61K31/47 , A61K31/404 , A61K31/4045 , A61K31/405 , A61K31/407 , A61K31/41 , A61K31/4184 , A61K31/4192 , A61K31/454 , A61K31/5377 , A61K45/06 , C07D209/08 , C07D233/64 , C07D403/12 , C07D405/12 , C07D405/14 , C07D471/04 , C07D487/04 , G01N33/5035 , G01N2333/705 , G01N2500/10
Abstract: Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.
Abstract translation: 本发明的化合物及其药学上可接受的组合物可用作ATP结合盒(“ABC”)转运蛋白或其片段的调节剂,包括囊性纤维化跨膜电导调节剂(“CFTR”)。 本发明还涉及使用本发明化合物治疗ABC转运蛋白介导的疾病的方法。
-
公开(公告)号:US20090298876A1
公开(公告)日:2009-12-03
申请号:US12351447
申请日:2009-01-09
Applicant: Sara Hadida Ruah , Anna Hazlewood , Peter D.J. Grootenhuis , Fredrick Van Goor , Ashvani Singh , Jinglan Zhou , Jason McCartney
Inventor: Sara Hadida Ruah , Anna Hazlewood , Peter D.J. Grootenhuis , Fredrick Van Goor , Ashvani Singh , Jinglan Zhou , Jason McCartney
CPC classification number: C07D471/10 , A61K8/4926 , A61K31/04 , A61K31/136 , A61K31/265 , A61K31/27 , A61K31/277 , A61K31/352 , A61K31/403 , A61K31/404 , A61K31/4045 , A61K31/44 , A61K31/47 , A61K31/4709 , A61K31/472 , A61K31/4747 , A61K31/538 , A61K31/5415 , A61K31/55 , A61K45/06 , C07C205/11 , C07C205/58 , C07C209/00 , C07C211/17 , C07C211/50 , C07C211/52 , C07C215/28 , C07C215/70 , C07C215/76 , C07C215/78 , C07C217/76 , C07C217/80 , C07C217/84 , C07C219/34 , C07C229/52 , C07C255/58 , C07C271/20 , C07C311/08 , C07C311/39 , C07C2601/14 , C07C2601/18 , C07C2602/10 , C07C2603/74 , C07D209/04 , C07D209/08 , C07D209/12 , C07D209/14 , C07D209/18 , C07D209/20 , C07D209/42 , C07D209/94 , C07D209/96 , C07D213/20 , C07D213/73 , C07D215/227 , C07D215/233 , C07D215/38 , C07D215/56 , C07D217/04 , C07D217/06 , C07D223/16 , C07D265/36 , C07D279/16 , C07D311/58 , C07D401/12 , C07D401/14 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12 , G01N33/48728 , G01N33/5035 , G01N33/566 , G01N33/6872 , G01N2333/705
Abstract: The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.
Abstract translation: 本发明涉及ATP结合盒(“ABC”)转运蛋白或其片段的调节剂,包括囊性纤维化跨膜电导调节剂,其组合物及其方法。 本发明还涉及使用这种调节剂治疗ABC转运蛋白介导的疾病的方法。
-
公开(公告)号:US07495103B2
公开(公告)日:2009-02-24
申请号:US11165818
申请日:2005-06-24
Applicant: Sara Hadida-Ruah , Anna Hazelwood , Peter Grootenhuis , Fred Van Goor , Ashvani Singh , Jinglan Zhou , Jason McCartney
Inventor: Sara Hadida-Ruah , Anna Hazelwood , Peter Grootenhuis , Fred Van Goor , Ashvani Singh , Jinglan Zhou , Jason McCartney
IPC: C07D215/38 , A61K31/44
CPC classification number: C07D471/10 , A61K8/4926 , A61K31/04 , A61K31/136 , A61K31/265 , A61K31/27 , A61K31/277 , A61K31/352 , A61K31/403 , A61K31/404 , A61K31/4045 , A61K31/44 , A61K31/47 , A61K31/4709 , A61K31/472 , A61K31/4747 , A61K31/538 , A61K31/5415 , A61K31/55 , A61K45/06 , C07C205/11 , C07C205/58 , C07C209/00 , C07C211/17 , C07C211/50 , C07C211/52 , C07C215/28 , C07C215/70 , C07C215/76 , C07C215/78 , C07C217/76 , C07C217/80 , C07C217/84 , C07C219/34 , C07C229/52 , C07C255/58 , C07C271/20 , C07C311/08 , C07C311/39 , C07C2601/14 , C07C2601/18 , C07C2602/10 , C07C2603/74 , C07D209/04 , C07D209/08 , C07D209/12 , C07D209/14 , C07D209/18 , C07D209/20 , C07D209/42 , C07D209/94 , C07D209/96 , C07D213/20 , C07D213/73 , C07D215/227 , C07D215/233 , C07D215/38 , C07D215/56 , C07D217/04 , C07D217/06 , C07D223/16 , C07D265/36 , C07D279/16 , C07D311/58 , C07D401/12 , C07D401/14 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12 , G01N33/48728 , G01N33/5035 , G01N33/566 , G01N33/6872 , G01N2333/705
Abstract: The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.
Abstract translation: 本发明涉及ATP结合盒(“ABC”)转运蛋白或其片段的调节剂,包括囊性纤维化跨膜电导调节剂,其组合物及其方法。 本发明还涉及使用这种调节剂治疗ABC转运蛋白介导的疾病的方法。
-
公开(公告)号:US20080009524A1
公开(公告)日:2008-01-10
申请号:US11824606
申请日:2007-06-29
Applicant: Sara Hadida Ruah , Mark Miller , Brian Bear , Jason McCartney , Peter Grootenhuis
Inventor: Sara Hadida Ruah , Mark Miller , Brian Bear , Jason McCartney , Peter Grootenhuis
IPC: A61K31/357 , A61K31/167 , A61K31/428 , A61P11/00 , A61P25/00 , A61P35/00 , C07C311/16 , C07D405/12 , C07D513/00 , C07D317/46 , C07C233/65 , A61P3/00 , A61P21/00 , A61K31/443 , A61K31/18
CPC classification number: C07D317/68
Abstract: Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.
-
公开(公告)号:US20070244159A1
公开(公告)日:2007-10-18
申请号:US11786001
申请日:2007-04-09
Applicant: Sara Hadida Ruah , Peter Grootenhuis , Frederick Van Goor , Jinglan Zhou , Brian Bear , Mark Miller , Jason McCartney , Mehdi Numa
Inventor: Sara Hadida Ruah , Peter Grootenhuis , Frederick Van Goor , Jinglan Zhou , Brian Bear , Mark Miller , Jason McCartney , Mehdi Numa
IPC: A61K31/454 , A61K31/42 , A61K31/4178 , A61K31/405 , C07D413/02 , C07D403/02
CPC classification number: C07D405/12 , C07B59/002 , C07B2200/05 , C07D403/12 , C07D405/14 , C07D471/04 , C07D487/04 , G01N33/5008 , G01N33/6872 , G01N2333/705 , G01N2500/02 , G01N2500/10
Abstract: Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.
Abstract translation: 本发明的化合物及其药学上可接受的组合物可用作ATP结合盒(“ABC”)转运蛋白或其片段的调节剂,包括囊性纤维化跨膜电导调节剂(“CFTR”)。 本发明还涉及使用本发明化合物治疗ABC转运蛋白介导的疾病的方法。
-
公开(公告)号:US08846753B2
公开(公告)日:2014-09-30
申请号:US13928719
申请日:2013-06-27
Applicant: Sara S Hadida Ruah , Mark T. Miller , Brian Bear , Jason McCartney , Peter D. J. Grootenhuis
Inventor: Sara S Hadida Ruah , Mark T. Miller , Brian Bear , Jason McCartney , Peter D. J. Grootenhuis
IPC: A61K31/357 , C07D317/54
CPC classification number: C07D498/04 , A61K31/167 , A61K31/357 , A61K31/381 , A61K31/40 , A61K31/437 , A61K31/443 , A61K31/519 , A61K31/538 , A61K45/06 , C07C235/16 , C07D207/48 , C07D317/54 , C07D317/60 , C07D317/68 , C07D405/12 , C07D409/12 , C07D413/12 , C07D471/04 , C07D487/04
Abstract: Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.
-
公开(公告)号:US20130296306A1
公开(公告)日:2013-11-07
申请号:US13928719
申请日:2013-06-27
Applicant: Sara S Hadida Ruah , Mark T. Miller , Brian Bear , Jason McCartney , Peter D.J. Grootenhuis
Inventor: Sara S Hadida Ruah , Mark T. Miller , Brian Bear , Jason McCartney , Peter D.J. Grootenhuis
IPC: C07D317/60
CPC classification number: C07D498/04 , A61K31/167 , A61K31/357 , A61K31/381 , A61K31/40 , A61K31/437 , A61K31/443 , A61K31/519 , A61K31/538 , A61K45/06 , C07C235/16 , C07D207/48 , C07D317/54 , C07D317/60 , C07D317/68 , C07D405/12 , C07D409/12 , C07D413/12 , C07D471/04 , C07D487/04
Abstract: Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.
Abstract translation: 本发明的化合物及其药学上可接受的组合物可用作ATP结合盒(“ABC”)转运蛋白或其片段的调节剂,包括囊性纤维化跨膜电导调节剂(“CFTR”)。 本发明还涉及使用本发明化合物治疗ABC转运蛋白介导的疾病的方法。
-
公开(公告)号:US08318733B2
公开(公告)日:2012-11-27
申请号:US13108077
申请日:2011-05-16
Applicant: Sara Sabina Hadida-Ruah , Matthew Hamilton , Mark Thomas Miller , Peter Diederik Jan Grootenhuis , Jinglan Zhou , Brian Richard Bear , Jason McCartney
Inventor: Sara Sabina Hadida-Ruah , Matthew Hamilton , Mark Thomas Miller , Peter Diederik Jan Grootenhuis , Jinglan Zhou , Brian Richard Bear , Jason McCartney
IPC: A61K31/5377 , A61K31/497 , A61K31/506 , A61K31/4418 , A61K31/443
CPC classification number: C07D405/12 , A61K31/443 , A61K31/444 , A61K31/4545 , A61K31/47 , A61K31/4709 , A61K31/496 , A61K31/497 , A61K31/501 , A61K31/506 , A61K31/5377 , A61K45/06 , C07D405/14
Abstract: Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.
-
公开(公告)号:US08101767B2
公开(公告)日:2012-01-24
申请号:US12351401
申请日:2009-01-09
Applicant: Sara Hadida Ruah , Anna Hazlewood , Peter D. J. Grootenhuis , Fredrick Van Goor , Ashvani Singh , Jinglan Zhou , Jason McCartney
Inventor: Sara Hadida Ruah , Anna Hazlewood , Peter D. J. Grootenhuis , Fredrick Van Goor , Ashvani Singh , Jinglan Zhou , Jason McCartney
IPC: C07D215/38
CPC classification number: C07D471/10 , A61K8/4926 , A61K31/04 , A61K31/136 , A61K31/265 , A61K31/27 , A61K31/277 , A61K31/352 , A61K31/403 , A61K31/404 , A61K31/4045 , A61K31/44 , A61K31/47 , A61K31/4709 , A61K31/472 , A61K31/4747 , A61K31/538 , A61K31/5415 , A61K31/55 , A61K45/06 , C07C205/11 , C07C205/58 , C07C209/00 , C07C211/17 , C07C211/50 , C07C211/52 , C07C215/28 , C07C215/70 , C07C215/76 , C07C215/78 , C07C217/76 , C07C217/80 , C07C217/84 , C07C219/34 , C07C229/52 , C07C255/58 , C07C271/20 , C07C311/08 , C07C311/39 , C07C2601/14 , C07C2601/18 , C07C2602/10 , C07C2603/74 , C07D209/04 , C07D209/08 , C07D209/12 , C07D209/14 , C07D209/18 , C07D209/20 , C07D209/42 , C07D209/94 , C07D209/96 , C07D213/20 , C07D213/73 , C07D215/227 , C07D215/233 , C07D215/38 , C07D215/56 , C07D217/04 , C07D217/06 , C07D223/16 , C07D265/36 , C07D279/16 , C07D311/58 , C07D401/12 , C07D401/14 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12 , G01N33/48728 , G01N33/5035 , G01N33/566 , G01N33/6872 , G01N2333/705
Abstract: The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.
Abstract translation: 本发明涉及ATP结合盒(“ABC”)转运蛋白或其片段的调节剂,包括囊性纤维化跨膜电导调节剂,其组合物及其方法。 本发明还涉及使用这种调节剂治疗ABC转运蛋白介导的疾病的方法。
-
-
-
-
-
-
-
-
-